HSANZ welcomes their charity and industry partners to offer a range of co-funded PhD Scholarships, Clinical Fellowships, grants and awards annually, biennially and triennially.

Current partners include:

Leukaemia Foundation

The Leukaemia Foundation was founded in 1975 by Brisbane's first clinical haematologist. Dr Trevor Olsen, together with the help of the Lions Club bought a lamina flow bed which was donated to the Mater Hospital. The new Foundation set four goals: to provide medical care, patient support, fund research and to educate patients, their families and nursing staff. Over the years, other states established their own Foundations and in 2016 it became a united organisation.

They are dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life. They reach 50% of all newly diagnosed people with blood cancer, whether they are located in metropolitan, regional or remote rural areas and have also invested millions into vital research into better treatments and cures.

The partnership with Leukaemia Foundation allows HSANZ to award up to three doctoral scholarships per year to Australian applicants demonstrating outstanding merit in blood cancer or blood cancer related disorders.

Marina Grunstein Walking Up the Hill Foundation

The Walking Up The Hill Foundation was established in 2016 in memory of Marina Grunstein who lived the last year of her life with Myeloma. One of the aims of the Foundation is to provide financial support for medical research, specifically in the field of myeloma.

The partnership with Walking Up the Hill Foundation allowed the inaugural PhD to be awarded in 2018.

Snowdome Foundation
Dr Bob Cannon OAM and Dr Jean Cannon

The Snowdome Foundation was formed in 2010 in memory of Chloe Rutherford who lost her brave fight with leukaemia. The foundation is named after her love for snowdomes. Snowdome’s mission is to accelerate next-generation treatments to Australian blood cancer patients to help them live better, longer lives.  Snowdome's focus is to channel philanthropic donations into funding research focussed on epigenetics, biomarkers, genomics and immunotherapy; all cutting edge approaches to personalised medicine. Since inception, Snowdome has raised over $36 million, and extended over 47 research grants to fund over 65 multi-year research positions.

The partnership with Snowdome offers the Dr Bob Cannon OAM and Dr Jean Cannon – Snowdome Foundation Myeloma Travel Grants, to be awarded annually to a myeloma trainee and a myeloma nurse. These travel grants are in memory of Bob and Jean Cannon who wished to assist researchers further their inquiries into myeloma by attending a scientific meeting to present their research findings and build their network. On behalf of Australian blood cancer patients, we thank the Cannon family for their generous gift to further research into myeloma.